BSE Live
Nov 19, 12:30Prev. Close
269.95
Open Price
266.10
Bid Price (Qty.)
265.40 (25)
Offer Price (Qty.)
266.20 (48)
NSE Live
Nov 19, 12:28Prev. Close
268.05
Open Price
268.05
Bid Price (Qty.)
265.70 (20)
Offer Price (Qty.)
266.00 (391)
| Key Financial Ratios of Indoco Remedies (in Rs. Cr.) | Jun 05 | Jun 04 | |
| Per Share Ratios | |||
| Basic EPS (Rs.) | 21.26 | 24.10 | |
| Diluted EPS (Rs.) | 21.26 | 24.10 | |
| Cash EPS (Rs.) | 25.85 | 28.31 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 148.32 | 99.78 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 148.33 | 99.79 | |
| Dividend / Share(Rs.) | 5.00 | 5.00 | |
| Revenue from Operations/Share (Rs.) | 164.45 | 176.42 | |
| PBDIT/Share (Rs.) | 36.35 | 37.62 | |
| PBIT/Share (Rs.) | 32.68 | 34.27 | |
| PBT/Share (Rs.) | 30.96 | 32.52 | |
| Net Profit/Share (Rs.) | 21.26 | 24.10 | |
| Profitability Ratios | |||
| PBDIT Margin (%) | 22.10 | 21.32 | |
| PBIT Margin (%) | 19.87 | 19.42 | |
| PBT Margin (%) | 18.82 | 18.43 | |
| Net Profit Margin (%) | 12.92 | 13.66 | |
| Return on Networth / Equity (%) | 14.33 | 24.15 | |
| Return on Capital Employed (%) | 12.58 | 21.34 | |
| Return on Assets (%) | 8.80 | 14.12 | |
| Total Debt/Equity (X) | 0.28 | 0.24 | |
| Asset Turnover Ratio (%) | 68.15 | 103.36 | |
| Liquidity Ratios | |||
| Current Ratio (X) | 1.79 | 1.98 | |
| Quick Ratio (X) | 1.43 | 1.53 | |
| Inventory Turnover Ratio (X) | 6.46 | 6.70 | |
| Dividend Payout Ratio (NP) (%) | 23.52 | 20.74 | |
| Dividend Payout Ratio (CP) (%) | 19.34 | 17.66 | |
| Earnings Retention Ratio (%) | 76.48 | 79.26 | |
| Cash Earnings Retention Ratio (%) | 80.66 | 82.34 | |
| Valuation Ratios | |||
| Enterprise Value (Cr.) | 352.09 | 0.00 | |
| EV/Net Operating Revenue (X) | 1.81 | 0.00 | |
| EV/EBITDA (X) | 8.19 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 1.70 | 0.00 | |
| Retention Ratios (%) | 76.47 | 79.25 | |
| Price/BV (X) | 1.88 | 0.00 | |
| Price/Net Operating Revenue | 1.70 | 0.00 | |
| Earnings Yield | 0.08 | 0.00 |
12.11.2025
Indoco Remedies Standalone September 2025 Net Sales at Rs 442.12 crore, up 11.5% Y-o-Y
07.11.2025
Indoco Remedies Consolidated September 2025 Net Sales at Rs 484.67 crore, up 12.02% Y-o-Y
25.07.2025
24.07.2025
Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y
12.11.2025
Indoco Remedies Standalone September 2025 Net Sales at Rs 442.12 crore, up 11.5% Y-o-Y
07.11.2025
Indoco Remedies Consolidated September 2025 Net Sales at Rs 484.67 crore, up 12.02% Y-o-Y
24.07.2025
Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y
24.07.2025
Indoco Remedies Standalone June 2025 Net Sales at Rs 392.53 crore, down 2.22% Y-o-Y
12.07.2023
Indoco Remedies Q1 PAT may dip 0.1% YoY to Rs 38.5 cr: Nirmal Bang
17.01.2023
Indoco Remedies Q3 PAT seen up 46.1% YoY to Rs 482 cr: Nirmal Bang
08.07.2022
Indoco Remedies Q1 PAT seen up 4.4% YoY to Rs 41.4 cr: Prabhudas Lilladher
14.04.2022
Indoco Remedies Q4 PAT seen up 52.9% YoY to Rs 38.2 cr: Prabhudas Lilladher